Prot# 219-00/COX540: A Randomized, Placebo-Controlled, Parallel-Group, Double-Blind Study to Evaluate the Safety and Efficacy of Rofecoxib 12.5 mg and Celecoxib 200 mg in Patients with Osteoarthritis of the Knee

Project: Research project

Project Details

StatusFinished
Effective start/end date9/2/031/31/05

Funding

  • Merck & Co., Inc. (219-00/COX540)